$0.00010
0.000.00%
At close: -
Comments
Loading...
Better Therapeutics (OTC:BTTX) Stock, Earnings Estimates, EPS, And Revenue
Better Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 9
EPS
$-0.150
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Better Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Better Therapeutics (BTTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-09 | $-0.15 | $-0.21 | 28.6 % |
| Jun 2023 | 2023-08-09 | $-0.24 | $-0.31 | 22.6 % |
| Mar 2023 | 2023-05-11 | $-0.39 | $-0.74 | 47.3 % |
| Dec 2022 | 2023-03-30 | $-0.37 | $-0.51 | 27.5 % |
Better Therapeutics (BTTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Better Therapeutics (OTCEM:BTTX) reporting earnings?
Better Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3.
What were the latest earnings per share (EPS) for Better Therapeutics (OTCEM:BTTX)?
Better Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual EPS was $-0.15, which beat the estimate of $-0.21.
What were Better Therapeutics’s (OTCEM:BTTX) revenues?
Better Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.